Marina Basina

Marina Basina, MD, Clinical Professor, Department of Medicine, Division of Endocrinology, Gerontology, and Metabolism, Stanford University School of Medicine 

Research Description: Dr. Basina is a clinical endocrinologist and clinical researcher with a focus on diabetes management. She is actively involved in the Stanford diabetes research community in multiple ways as described below. Dr. Basina was a co-investigator on an NIH-sponsored research study of Safety and Efficacy of Sensor- Augmented Continuous Subcutaneous Insulin Infusion in Patients with Diabetic Gastroparesis. Dr. Basina has served as a Stanford site primary investigator of a Sanofi sponsored multi-center research study comparing two different insulins for diabetes control and the incidence of hypoglycemia in patients undergoing hemodialysis with diabetes-related End Stage Renal disease. She also served as a PI on a Novo Nordisk sponsored multicenter randomized controlled trial comparing two basal insulins (Lantus and Degludec) for type 2 diabetes (NN1250-4252 - Site 164). 

She has previously collaborated with other SDRC members (Abbasi, McLaughlin, Reaven*) in published studies of insulin resistance, dietary interventions and diabetes-associated cardiovascular disease risk. Dr Basina is a co-investigator on Expansion and Evaluation of ECHO (Extension for Community Healthcare Outcomes) for diabetics on Intensive Insulin Therapy. The overall goal of this study, funded by Helmsley Foundation, Inc., is to build an innovative healthcare delivery model to effectively manage underserved patients with type 1 Diabetes who do not receive routine specialty care. She is also a co-investigator of a working group in the NCI/NIDDK funded multi-center consortium (CPDPC) that is actively involved in recruiting pancreatitis patients in order to understand progression from recurrent acute to chronic pancreatitis 

In addition, Dr. Basina is a co-leader with Dr. Justin Annes of Enrichment activities in SDRC, with a focus on community outreach efforts (detailed in the Enrichment section of this proposal). Finally, Dr. Basina will focus on clinical care of subjects undergoing islet auto-transplantation in the SPIRIT program developed by several SDRC members, including Drs. Kraemer, S.K. Kim, Maahs, Meyer, Park, Thakor and Visser. 

Selected relevant publications (Stanford DRC Members in BOLD):

  1. Erkers T, Xie BJ, Kenyon LJ, Smith B, Rieck M, Jensen KP, Ji X, Basina M, Strober S, Negrin RS, Maecker HT, Meyer EH. High-parametric evaluation of human invariant natural killer T cells to delineate heterogeneity in allo- and autoimmunity. Blood. 2020 Mar 12;135(11):814-825. doi: 10.1182/blood.2019001903. PMID: 31935280; PMCID: PMC7068034. 

  2. Lal RA, Basina M, Maahs DM, Hood K, Buckingham B, Wilson DM. One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System. Diabetes Care. 2019 Dec;42(12):2190-2196. doi: 10.2337/dc19-0855. PMID: 31548247; PMCID: PMC6868462. 

  3. Lal RA, Cuttriss N, Haller MJ, Yabut K, Anez-Zabala C, Hood KK, Sheehan E, Basina M, Bernier A, Baer LG, Filipp SL, Wang CJ, Town MA, Gurka MJ, Maahs DM, Walker AF. Primary Care Providers in California and Florida Report Low Confidence in Providing Type 1 Diabetes Care. Clin Diabetes. 2020 Apr;38(2):159-165. doi: 10.2337/cd19-0060. PMID: 32327888; PMCID: PMC7164993.